Top 10 Biotech Angel Investors in Italy (October 2023)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Laura Iris Ferro
Angel
|
2 | Italy | Pre-Seed | Health Care, Biotechnology, Medical Device | |
|
Elena Paola Lanati
Angel
|
1 | Italy | Seed | Biotechnology, Manufacturing, Nanotechnology | |
|
Michael Gebert
Angel
|
1 | Italy | Seed | Health Care, Biotechnology | |
|
Enrico Pandian
Angel
|
1 | Italy, United States | Seed, Angel, Pre-Seed | E-Commerce, SaaS, FinTech | |
|
Mauro Cogoli
Angel
|
1 | Italy | Seed | Health Care, Biotechnology | |
|
Giovanni Zobele
Angel
|
1 | Italy | Seed | Health Care, Biotechnology | |
|
Stefano Bernardi
Angel
|
1 | Italy, France, Norway | Seed, Pre-Seed | Software, Biotechnology, Cryptocurrency | $2M–$2M |
|
Stefano De Rossi
Angel
|
1 | Italy | Seed | Health Care, Biotechnology | |
|
Harald Oberrauch
Angel
|
1 | Italy | Seed | Health Care, Biotechnology | |
|
Hermann Hauser
Angel
|
1 | Austria, United Kingdom, Italy | Series A, Seed | Software, Machine Learning, Artificial Intelligence | $514k–$16M |
| Access all 10 angel investors in Italy Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Investor list
Laura Iris Ferro
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
Elena Paola Lanati
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Nanotechnology
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.
Michael Gebert - Chairman @ European Blockchain Association
Show more...Investment focus
- Industry: Health Care, Biotechnology
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.
Enrico Pandian is the Co-Founder and CEO of StartupGym and the Founder of FrescoFrigo. He previously worked at Checkout Technologies as a Co-Founder and President of the Board. Enrico Pandian attended the University of Verona.
Show more...Investment focus
- Industry: E-Commerce, SaaS, FinTech
- Stage:Seed, Angel, Pre-Seed
- Geography: Italy, United States
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Quisto — On Quisto, Ho.Re.Ca. retailers can find the best suppliers in their area and purchase 24/7 whatever they need for their business --> www.quisto.it
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Viceversa — Viceversa provides capital to European digital businesses to support companies in sustainable and ethical growth. The company was founded in 2021 and has locations in Milan and Dublin.
Mauro Cogoli
Show more...Investment focus
- Industry: Health Care, Biotechnology
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.
Giovanni Zobele
Show more...Investment focus
- Industry: Health Care, Biotechnology
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more...Investment focus
- Industry: Software, Biotechnology, Cryptocurrency
- Stage:Seed, Pre-Seed
- Geography: Italy, France, Norway
Investor stats
- Total investments: 13
- Round size: Pre-Seed $2M–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Freatic — We bridge the gap between individuals with untapped knowledge and actors who can take advantage of these opportunities.
- Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
Stefano De Rossi - Founder, CEO @ Leaning Technologies
Show more...Investment focus
- Industry: Health Care, Biotechnology
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.
Harald Oberrauch
Show more...Investment focus
- Industry: Health Care, Biotechnology
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.
Hermann Hauser co-founded Amadeus Capital Partners in 1997 with Anne Glover and Peter Wynn. In his long and successful history as an entrepreneur and venture capitalist, Hermann has founded or co-founded companies in a wide range of technology sectors. These include Acorn Computers (where he helped spin out ARM), Active Book Company,Virata, Net Products, NetChannel and Cambridge Network Limited. He was a founder director of IQ (Bio), IXI Limited, Vocalis, SynGenix, Advanced Displays Limited (acquired by Cambridge Display Technology), Electronic Share Information Limited, E*Trade UK and has supported many other start-ups.Hermann’s successes at Amadeus include: CSR plc (LON: CSR); Entropic Research Laboratory (acquired by Microsoft in 1999); Solexa (acquired by Illumina in 2007); and Icera (acquired by Nvidia in 2011). He is currently a non-executive director of XMOS, a company that is revolutionising re-configurable silicon chips; Intune Networks, a pioneer in the field of Optical Packet Switch & Transport; Tobii, the world leader in eye tracking and gaze detection; Plastic Logic, the first company to commercialize flexible plastic transistors (currently used in computer displays); and Cambridge Broadband Networks, a leader in point-to-multipoint wireless backhaul products.Hermann holds an MA in Physics from Vienna University and a PhD in Physics from the University of Cambridge. He is a Fellow of the Institute of Physics and of the Royal Academy of Engineering, and an Honorary Fellow of King's College, Cambridge. Hermann holds honorary doctorates from the Universities of Bath, Loughborough and from Anglia Ruskin University and was awarded an Honorary CBE for ‘innovative service to the UK enterprise sector’ in 2001. In 2004, he was made a member of the Government’s Council for Science & Technology. In 2012 he became a Fellow of the Royal Society in recognition of his contribution to the translation of science into business, and in 2013 a Distinguished Fellow of BCS, the Chartered Institute for IT.Austrian by birth, Hermann speaks German, English and conversational Italian and French.
Show more...Investment focus
- Industry: Software, Machine Learning, Artificial Intelligence
- Stage:Series A, Seed
- Geography: Austria, United Kingdom, Italy
Investor stats
- Total investments: 64
- Round size: Seed $514k–$6.4M; Series A $1.2M–$16M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- NXRT — Driving simulations for sales and training
- USound — USound is a fabless audio company offering high-performance silicon speakers and high-quality sound solutions based on MEMS (Micro-Electro-Mechanical Systems) technology. It is our vision to inspire music enthusiasts and acoustic professionals with crisp, natural sound for a fantastic hearing experience.
- Oxford Ionics — Oxford Ionics is delivering world-leading innovations to create the most powerful, accurate and reliable quantum computers.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Angel Investors in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 angel investors investing in Italy Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Sign up with Google
Sign up with LinkedIn
